Skip to Content

Join the 'Hepatic Encephalopathy' group to help and get support from people like you.

Hepatic Encephalopathy News

FDA Approves New Use of Xifaxan for Patients with Liver Disease

Posted 29 Mar 2010 by

SILVER SPRING, Md., March 24 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved the use of Xifaxan for reduction in the risk of the recurrence of overt hepatic encephalopathy (HE) in patients with advanced liver disease. This is a new use for Xifaxan (rifaximin), a drug that has been approved for the treatment of traveler's diarrhea. Hepatic encephalopathy is a ...

Ask a Question

Further Information

Related Condition Support Groups


Related Drug Support Groups

lactulose, Xifaxan, neomycin, rifaximin, Duphalac, Kristalose, Enulose, Constilac, Heptalac, view more... Evalose, Cholac, Mycifradin, Cephulac, Chronulac, Neo-Tab, Generlac, Neo-Fradin, Constulose, Chronulac Syrup